# Angioline to build $7.8M medical device plant in Novosibirsk

AO Angioline will invest over 500 million rubles (approx. $7.8 million) to build a plant in Novosibirsk, Russia, producing aortic valves, venous cava filters, occluders and vascular implants. The project is in partnership with the Meshalkin Research Center and is expected to launch in 2020.

- Type: New facility
- Announced: 2017-05-29
- Where: Novosibirsk, Russia
- Value: $7.80M (500.0M RUB)
- Starts operating: 2020
- Status: announced
- Products: aortic valves, venous cava filters, occluders, vascular implants
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Angioline](https://endata.com/companies/24528.md)
- [Siberian Federal Biomedical Research Center](https://endata.com/companies/24540.md) (partner)

## Sources

- [vademec.ru](https://vademec.ru/news/2017/05/26/angiolayn-vlozhit-bolee-500-mln-rubley-v-novoe-proizvodstvo-i-oborudovanie/), 2017-05-29: "АО «Ангиолайн» вложит более 500 млн рублей в создание завода, который будет выпускать четыре новых для предприятия вида продукции"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.